[Prophylactic mastectomy and occult cancer: a ten-year experience at a cancer center]

Bull Cancer. 2021 Nov;108(11):999-1009. doi: 10.1016/j.bulcan.2021.05.007. Epub 2021 Sep 21.
[Article in French]

Abstract

Introduction: Women identified as high-risk for breast cancer may choose between close follow-up and radical mastectomy. Prophylactic mastectomy, as any other surgery, is associated with benefits and harms. The aim of this study was to assess the morbidity associated with prophylactic mastectomy and to evaluate the prevalence of occult cancers.

Methods: All patients who underwent unilateral or bilateral prophylactic mastectomy between 2007 and 2017 in our institution were eligible for inclusion in this retrospective study. Medical history, type of surgery, occurrence of complication or reoperation and pathological reports were examined in medical charts.

Results: 79 women underwent prophylactic mastectomy over the studied period of which 58.2% were contralateral after breast cancer. A genetic mutation was present in 86.1% of cases. Postoperative complications occurred in 43.0% of cases. An additional surgery for medical or esthetic purpose was needed in 72.1% of cases. Occult cancer was found in 11.4% of the pathological reports. Triple negative invasive ductal carcinoma was discovered in two cases (2.5%).

Discussion: Prophylactic mastectomy is the only effective preventive action against breast cancer. Women must be clearly informed of possible complications, high reoperation rate and potential pathological findings. Identifying women most at risk for breast cancer would help to better target those who will benefit most from surgery.

Keywords: BRCA mutation; Breast cancer; Cancer du sein; Cancer occulte; Chirurgie préventive; Complication; Mutation BRCA; Occult cancer; Prophylactic surgery; Reoperation; Réintervention.

MeSH terms

  • Adult
  • Aged
  • Breast Neoplasms / diagnostic imaging
  • Breast Neoplasms / epidemiology*
  • Breast Neoplasms / genetics
  • Cancer Care Facilities
  • Female
  • Genes, BRCA1
  • Genes, BRCA2
  • Humans
  • Middle Aged
  • Mutation
  • Neoplasms, Unknown Primary / diagnostic imaging
  • Neoplasms, Unknown Primary / epidemiology*
  • Neoplasms, Unknown Primary / genetics
  • Postoperative Complications / epidemiology*
  • Prevalence
  • Prophylactic Mastectomy / adverse effects*
  • Prophylactic Mastectomy / methods
  • Reoperation
  • Retrospective Studies
  • Time Factors